Tech Company Financing Transactions
Amira Pharmaceuticals Funding Round
On 11/28/2005, Amira Pharmaceuticals raised $6 million in Series A investment from Prospect Venture Partners and Versant Ventures.
Transaction Overview
Company Name
Announced On
11/28/2005
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series A
Investors
Prospect Venture Partners (James Tananbaum)
Versant Ventures (Bradley Bolzon)
Proceeds Purpose
Proceeds will be used for internal product development as well as potentially in-licensing two compounds from a major pharmaceutical company.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
9535 Waples St. 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Amira Pharmaceuticals is a privately-held biopharmaceutical company, focused on leveraging the deep expertise of a team of scientists in the field of inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Baltera
Chief Financial Officer
Michael Swanson
Chief Scientific Officer
Peppi Prasit
Vice President
Isabelle DeArmond
Vice President
Jilly Evans
Vice President
John Hutchinson
Browse more venture capital transactions:
Prev: 11/28/2005: Naviscan PET Systems venture capital transaction
Next: 11/29/2005: PlateSpin venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs